Tatva Chintan Pharma Chem Limited (TATVA) - Cash Flow Conversion Efficiency

Latest as of September 2023: 0.019x

Based on the latest financial reports, Tatva Chintan Pharma Chem Limited (TATVA) has a cash flow conversion efficiency ratio of 0.019x as of September 2023. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs135.54 Million ≈ $1.47 Million USD) by net assets (Rs7.27 Billion ≈ $78.66 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Tatva Chintan Pharma Chem Limited - Cash Flow Conversion Efficiency Trend (2018–2025)

This chart illustrates how Tatva Chintan Pharma Chem Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read how much debt does Tatva Chintan Pharma Chem Limited carry for a breakdown of total debt and financial obligations.

Tatva Chintan Pharma Chem Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Tatva Chintan Pharma Chem Limited ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Test Rite International Co Ltd TW:2908	0.118x
Danal Co. Ltd KQ:064260	-0.042x
GEOPARK LTD. DL -001 F:G6O	N/A
Springsnow Food Group Co Ltd SHG:605567	0.063x
PharmaSGP Holding SE F:PSG	0.115x
Fusion Micro Finance Limited NSE:FUSION	0.232x
Suzhou Shijing Environmental Technology Co.Ltd. SHE:301030	N/A
EUROSEAS LTD DL -01 F:2LE1	N/A

Annual Cash Flow Conversion Efficiency for Tatva Chintan Pharma Chem Limited (2018–2025)

The table below shows the annual cash flow conversion efficiency of Tatva Chintan Pharma Chem Limited from 2018 to 2025. For the full company profile with market capitalisation and key ratios, see TATVA company net worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-03-31	Rs7.39 Billion ≈ $79.90 Million	Rs246.71 Million ≈ $2.67 Million	0.033x	-74.90%
2024-03-31	Rs7.37 Billion ≈ $79.71 Million	Rs980.44 Million ≈ $10.60 Million	0.133x	+146.47%
2023-03-31	Rs5.15 Billion ≈ $55.67 Million	Rs277.83 Million ≈ $3.00 Million	0.054x	+25.29%
2022-03-31	Rs4.73 Billion ≈ $51.16 Million	Rs203.78 Million ≈ $2.20 Million	0.043x	-70.60%
2021-03-31	Rs1.66 Billion ≈ $17.95 Million	Rs243.19 Million ≈ $2.63 Million	0.147x	-31.87%
2020-03-31	Rs1.18 Billion ≈ $12.73 Million	Rs253.12 Million ≈ $2.74 Million	0.215x	+133.02%
2019-03-31	Rs797.00 Million ≈ $8.62 Million	Rs73.56 Million ≈ $795.52K	0.092x	-47.56%
2018-03-31	Rs591.56 Million ≈ $6.40 Million	Rs104.12 Million ≈ $1.13 Million	0.176x	--

About Tatva Chintan Pharma Chem Limited

NSE:TATVA India Specialty Chemicals

Market Cap

$331.65 Million

Rs30.67 Billion INR

Market Cap Rank

#14547 Global

#702 in India

Share Price

Rs1311.00

Change (1 day)

+1.29%

52-Week Range

Rs704.35 - Rs1588.70

All Time High

Rs2866.25